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We developed the engineered DNA- binding molecule- mediated chromatin immuno-
precipitation (enChIP) technology to isolate specific genomic regions while retain-
ing their molecular interactions. In enChIP, the locus of interest is tagged with an 
engineered DNA- binding molecule, such as a modified form of the clustered regu-
larly interspaced short palindromic repeats (CRISPR) system containing a guide 
RNA (gRNA) and a catalytically inactive form of Cas9 (dCas9). The locus is then 
affinity- purified to enable identification of associated molecules. In this study, we 
generated transgenic mice expressing 3xFLAG- tagged Streptococcus pyogenes 
dCas9 (3xFLAG- dCas9) and retrovirally transduced gRNA into primary CD4+ T 
cells from these mice for enChIP. Using this approach, we achieved high yields of 
enChIP at the targeted genomic region. Our novel transgenic mouse lines provide a 
valuable tool for enChIP analysis in primary mouse cells.
1 |  INTRODUCTION
Identification of molecules associated with a genomic region 
of interest in vivo is an essential step in understanding the 
regulatory mechanisms underlying that region’s functions. 
To this end, we previously developed engineered DNA- 
binding molecule- mediated chromatin immunoprecipitation 
(enChIP) technology to isolate genomic regions of interest 
along with their interacting molecules (Fujita & Fujii, 2013; 
Fujita et al., 2013). In enChIP, the locus of interest is tagged 
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with engineered DNA- binding molecules, such as transcrip-
tion activator- like (TAL) proteins (Bogdanove & Voytas, 
2011) or a variant of the clustered regularly interspaced short 
palindromic repeats (CRISPR) system (Harrison, Jenkins, 
O’Connor- Giles, & Wildonger, 2014; Wright, Nuñez, & 
Doudna, 2016) containing a guide RNA (gRNA) and a cat-
alytically inactive form of Cas9 (dCas9). The tagged locus 
is then affinity- purified to enable identification of associated 
molecules. Locus- tagging can be achieved in cells by ex-
pressing engineered DNA- binding molecules (Fujita & Fujii, 
2013, 2014b; Fujita, Yuno, & Fujii, 2016a; Fujita, Yuno, 
Okuzaki, Ohki, & Fujii, 2015; Fujita, Yuno, Suzuki, Sugano, 
& Fujii, 2017; Fujita et al., 2013), or in vitro using recombi-
nant or synthetic engineered DNA- binding molecules (Fujita 
& Fujii, 2014a; Fujita, Yuno, & Fujii, 2016b; Fujita, Kitaura, 
et al., 2017). Combination of enChIP with mass spectrom-
etry (MS), RNA sequencing, and next- generation sequenc-
ing (NGS) enables identification of proteins (Fujita & Fujii, 
2013, 2014b; Fujita et al., 2013), RNAs (Fujita et al., 2015), 
and other genomic regions (Fujita, Kitaura, et al., 2017; 
Fujita, Yuno, et al., 2017) that interact with specific loci of 
interest in a nonbiased manner.
To perform locus- tagging in primary cells, it is necessary 
to express both dCas9 and gRNA by transduction or other 
methods. However, the low transduction efficiency of some 
cell lineages results in a low percentage of cells expressing 
both dCas9 and gRNA. To resolve this technical issue, we 
generated transgenic (Tg) mouse lines expressing 3xFLAG- 
tagged Streptococcus pyogenes dCas9 (3xFLAG- dCas9), 
either constitutively or inducibly. To facilitate their use in 
various experimental contexts, expression of the tagged 
dCas9 and/or a reporter green fluorescent protein (GFP) can 
be flexibly induced or abolished by Cre- or FLPe- mediated 
site- specific recombination events that delete expression- 
modulating cassettes. We anticipate that these novel Tg 
mouse lines will serve as a powerful tool for efficient enChIP 
analysis in primary cells.
2 |  RESULTS AND DISCUSSION
2.1 | Generation of Tg mouse lines 
expressing 3xFLAG- dCas9
To facilitate enChIP analysis using primary mouse cells, we 
generated two Tg mouse lines expressing 3xFLAG- dCas9 
(Figure 1a,b). One line, 3xFLAG- dCas9- IRES- EGFP, har-
bors 3xFLAG- dCas9 and IRES- EGFP in the Rosa26 locus 
(Figure 1a). In the other line, 3xFLAG- dCas9 and IRES- 
EGFP are present at the Rosa26 locus, but expression of 
3xFLAG- dCas9 can be induced by Cre- mediated deletion 
of the STOP cassette (along with the neor gene), and EGFP 
expression can be disrupted by FRT- mediated deletion of 
the IRES- EGFP cassette (Figure 1b (i)). 3xFLAG- dCas9/
CTV (neo+/GFP+) mice were crossed with CAG- Cre mice 
(Matsumura, Hasuwa, Inoue, Ikawa, & Okabe, 2004) to delete 
the STOP cassette and neor gene, yielding 3xFLAG- dCas9/
CTV (GFP+) mice (Figure 1b (ii)). 3xFLAG- dCas9/CTV 
(GFP+) mice can be further crossed with CAG- FLPe mice 
(Schaft, Ashery- Padan, van der Hoeven, Gruss, & Stewart, 
2001) to delete the IRES- EGFP cassette, yielding 3xFLAG- 
dCas9/CTV mice (Figure 1b (iii)). Targeted integration of 
transgenes was confirmed by PCR (Figure 1c). All mice were 
viable and fertile with normal litter sizes and did not exhibit 
any morphological abnormalities. Expression of EGFP was 
observed throughout the body, including thymocytes and 
splenocytes (Figure 2a), and 3xFLAG- dCas9 was detected in 
nuclear extracts (NE) of thymocytes (Figure 2b). In conven-
tional enChIP using primary cells from mice, it is necessary 
to transduce both tagged dCas9 and gRNA. To compare the 
number of Tg mice required for enChIP with that required 
for conventional enChIP, we isolated CD4+ T cells from a 
wild- type C57BL/6 mouse and transduced them with a retro-
viral plasmid expressing 3xFLAG- dCas9 (3xFLAG- dCas9/
MSCV- EGFP). As shown in Figure S1, the transduction effi-
ciency of 3xFLAG- dCas9/MSCV- EGFP was approximately 
10%. Considering that all cells express 3xFLAG- dCas9 in 
our Tg mice (Figure 2a), this means that 10 times more mice 
are required for conventional enChIP than for enChIP using 
our Tg mice. Thus, our Tg mouse lines have the advantage of 
reducing the number of mice required for enChIP, as well the 
time and effort needed to perform enChIP analysis in primary 
mouse cells.
2.2 | enChIP analysis using primary CD4+ 
T cells
Next, we performed enChIP analysis using primary cells from 
the Tg mice (Figure 3a). For these experiments, CD4+ T cells 
were purified from 3xFLAG- dCas9- IRES- EGFP mice and 
3xFLAG- dCas9/CTV (GFP+) mice and activated with anti-
 CD3 and anti- CD28 antibodies (Abs). The activated cells 
were transduced with a retroviral vector expressing gRNA tar-
geting the c- myc promoter (m- c- myc gRNA #1/pSIR- hCD2) 
or a negative control vector (pSIR- hCD2), and 2 days later, 
hCD2+ cells were isolated and expanded in media contain-
ing IL- 2. Cells were fixed with formaldehyde and subjected 
to enChIP analysis using anti- FLAG Ab. Yields of enChIP 
were monitored by real- time PCR. As shown in Figure 3b,c, 
efficient enrichment of the c- myc promoter region, but not 
irrelevant loci (Gapdh, Pax5), was detected in samples ex-
pressing gRNA targeting the c- myc locus. By contrast, no en-
richment was observed for samples in the absence of gRNA. 
The yields of enChIP were comparable between 3xFLAG- 
dCas9- IRES- EGFP mice and 3xFLAG- dCas9/CTV (GFP+) 
mice. These results show that primary cells from these Tg 
mice can be used for enChIP analysis.






















































1, 3, 6: C57BL/6
2:         3xFLAG-dCas9-IRES-EGFP
5, 8:     3xFLAG-dCas9/CTV (GFP+)
4, 7:     3xFLAG-dCas9/CTV (neo+/GFP+)
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(a) ROSA-5′ TF2 (27699) x Cas9-R (27644)
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(b) ROSA-5′ TF2 (27699) x oIMR0013 (26013)
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F I G U R E  1  Generation of Tg mouse lines expressing 3xFLAG- dCas9. (a) Scheme of the targeted locus of 3xFLAG- dCas9- IRES- EGFP. 
(b) Scheme of the targeted loci of (i) 3xFLAG- dCas9/CTV (neo+/GFP+), (ii) 3xFLAG- dCas9/CTV (GFP+), and (iii) 3xFLAG- dCas9/CTV. (c) 
Genotyping PCR of Tg mouse lines
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3 |  CONCLUSIONS
We generated Tg mouse lines expressing 3xFLAG- tagged 
dCas9 and retrovirally transduced gRNA targeting a genomic 
locus into primary CD4+ T cells from these mice. Using this 
approach, high yields of enChIP could be achieved. Thus, 
these Tg mouse lines represent a useful tool for enChIP 
analysis in primary mouse cells. The injection of adenovirus- 
mediated gRNA (Platt et al., 2014) into these Tg mice should 
also enable the isolation of genomic regions of interest from 
mouse tissues without the need for primary cell cultures. In 
addition, the Tg mouse strains generated in this study could 
be used for CRISPR interference (CRISPRi) experiments (Qi 
et al., 2013) using primary mouse cells. However, in  enChIP 
analysis, such CRISPRi effects might be problematic. Thus, 
it would be better to choose gRNA target sequences that 
bind to the CRSIPR complex without interfering with the 
 functions of the target genomic regions.
4 |  EXPERIMENTAL PROCEDURES
4.1 | Plasmids
To construct pCAG1.2- PM, a modified pCAGGS plasmid (Niwa, 
Yamamura, & Miyazaki, 1991) was digested with SacI. Two 
oligonucleotides, MluI–PmeI oligo- S (27551) and MluI–PmeI 
oligo- A (27552), were annealed, phosphorylated, and inserted 
into the digested plasmid, yielding two plasmids, pCAG1.2- PM 
(PmeI–MluI) and pCAG1.2- MP (MluI–PmeI), distinguished by 
the orientations of the oligonucleotides. To construct 3xFLAG- 
dCas9/pCAG1.2- PM, pCAG1.2- PM was digested with EcoRV 
and NotI. 3xFLAG- dCas9/pMXs- puro (Addgene #51240) was 
digested with PacI, blunted, and further digested with NotI. 
The vector backbone and the coding sequence of 3xFLAG- 
dCas9 were purified by agarose gel electrophoresis and ligated. 
To construct 3xFLAG- dCas9- IG/pCAG1.2- PM, 3xFLAG- 
dCas9/pCAG1.2- PM and 3xFLAG- dCas9/pMXs- IG (Addgene 
#51258) were digested with NotI and SalI, respectively. After 
blunting, the plasmids were further digested with AscI. The vec-
tor backbone and the coding sequence of 3xFLAG- dCas9 were 
purified by agarose gel electrophoresis and ligated. To construct 
3xFLAG- dCas9- IG/pSKII- ROSA, pSKII- ROSA26arm0.5 kb- 
zeo was digested with BamHI and SalI, and 3xFLAG- dCas9- IG/
pCAG1.2- PM was digested with MluI and PacI. After blunting, 
the vector backbone and the coding sequence of 3xFLAG- dCas9 
were purified by agarose gel electrophoresis and ligated.
To construct 3xFLAG- dCas9/CTV, CTV (Addgene 
#15912) was digested with AscI and 3xFLAG- dCas9/pMXs- 
puro was digested with PacI and NotI. After blunting, the 
vector backbone and the coding sequence of 3xFLAG- dCas9 
were purified by agarose gel electrophoresis and ligated.
To construct 3xFLAG- dCas9/MSCV- EGFP (Addgene 
#82613), the MSCV- EGFP plasmid (DeKoter, Walsh, & 
Singh, 1998) was digested with Hpa I and ligated with the 
coding sequence of 3xFLAG- dCas9, which was derived 
F I G U R E  2  Expression of 3xFLAG- 
dCas9. (a) Expression of green fluorescent 
protein (GFP) in thymocytes and 
splenocytes from Tg mice. Fluorescence 
in the FL- 1 channel (GFP) is shown for 
C57BL/6 mice (WT: black) and Tg mice 
(Tg: green). Numbers represent mean 
fluorescence intensities (MFI) in the FL- 1 
channel. (b) Expression of 3xFLAG- dCas9 
in thymocytes from Tg mice. Expression 
of 3xFLAG- dCas9 was detected by 
immunoblot analysis with anti- FLAG Ab. 
Coomassie Brilliant Blue (CBB) staining is 
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from 3xFLAG- dCas9/pMXs- puro by digesting with Pac 
I and Not I followed by blunting with DNA Blunting Kit 
(Takara).
To construct a gBlock targeting the mouse c- myc pro-
moter, the oligonucleotides mcMYC promoter 1 sense 
(27822) and mcMYC promoter 1 antisense (27823) were 
annealed, phosphorylated, and inserted into gRNA clon-
ing vector BbsI ver. 1 digested with BbsI. To construct m- 
c- myc gRNA #1/pSIR, the gBlock was excised with XhoI 
and HindIII and inserted into XhoI/HindIII- cleaved pSIR 
(Clontech). To construct a retroviral vector for expression 
of gRNA against the mouse c- myc promoter (m- c- myc 
gRNA #1/pSIR- hCD2), pSIR- hCD2 (Addgene #51143) 
and m- c- myc gRNA #1/pSIR were digested with SanDI and 
HindIII. The vector backbone and insert were purified by 
agarose gel electrophoresis and ligated.
Oligonucleotides used for construction of plasmids are 
shown in Table 1.
4.2 | Mice
Embryonic stem (ES) cells (EGR- 101) (Fujihara, Kaseda, 
Inoue, Ikawa, & Okabe, 2013) were transfected with linearized 
3xFLAG- dCas9- IG/pSKII- ROSA, as described previously 
(Oji et al., 2016). ES cells retaining the transgene in the Rosa26 
locus were injected into blastocysts (ICR × ICR) to generate 
chimeric mice. The chimeric mice were crossed with B6D2F1 
mice to generate heterozygous 3xFLAG- dCas9- IRES- EGFP 
mice (strain name: B6D2- Gt(ROSA)26Sorem1(CAG-3XFLAG/
dCas9,-EGFP)Osb) (RIKEN BioResource Center RBRC09976; 
Kumamoto University Center for Animal Resources and 
Development (CARD): CARD ID 2531).
B6JN/1 ES cells (Moriyama et al., 2014), derived from a hy-
brid between C57BL/6J and C57BL/6N, were electroporated 
with 3xFLAG- dCas9/CTV plasmid linearized with AsiSI. To 
generate chimeric mice, ES cells containing the neor gene, 
transgene, and GFP gene in the Rosa26 locus were injected into 
blastocysts (Balb/c  ×  Balb/c) by the animal facility group at 
RIKEN IMS. The chimeric mice were crossed with C57BL/6 
mice to generate heterozygous 3xFLAG- dCas9/CTV (neo+/
GFP+) mice (strain name: C57BL/6- Gt(ROSA)26Sortm1(CAG-
3XFLAG/dCas9,-EGFP)Hfuj) (RIKEN BioResource Center 
RBRC10188). The 3xFLAG- dCas9/CTV (neo+/GFP+) mice 
were crossed with CAG- Cre mice (Matsumura et al., 2004) 
to generate 3xFLAG- dCas9/CTV (GFP+) mice (strain name: 
C57BL/6- Gt(ROSA)26Sortm1.1(CAG-3XFLAG/dCas9,-EGFP)Hfuj) 
F I G U R E  3  enChIP analysis of CD4+ 
T cells from 3xFLAG- dCas9 Tg mice. (a) 
Scheme of enChIP analysis using Tg mouse 
lines. (b) Positions of primer sets used for 
enChIP real- time PCR. Green letters: primer 
positions for c- myc (1); red letters: primer 
positions for c- myc (2); yellow highlight: 
gRNA target site; underline: PAM. (c) 
Yields of enChIP analysis for the target site. 
Error bars represent differences between 
duplicate analyses. N.D.: not detected. 
Irrelevant loci (Gapdh and Pax5) were 
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(RIKEN BioResource Center RBRC10189). The 3xFLAG- 
dCas9/CTV (GFP+) mice can be crossed with CAG- FLPe 
mice (Schaft et al., 2001) to generate 3xFLAG- dCas9/CTV 
mice (strain name: C57BL/6- Gt(ROSA)26Sortm1.2(CAG-3XFLAG/
dCas9)Hfuj) (RIKEN BioResource Center RBRC10190).
All animal experiments were approved by the Institutional 
Animal Care and Use Committee at Research Institute for 
Microbial Diseases, Osaka University.
4.3 | Genotyping
For genotyping, genomic DNA was extracted and sub-
jected to PCR with KOD FX (Toyobo). PCR conditions 
were as follows: heating at 94°C for 2 min; followed by 
38 cycles of 98°C for 10 s, 62°C for 30 s, and 68°C for 
4 min. Primers used for genotyping PCR are shown in 
Table 1.
4.4 | Cell staining and flow cytometry
Thymi and spleens were isolated from euthanized mice and 
used to prepare single cells. For surface staining, cells were 
stained for 30 min at 4°C with fluorochrome- conjugated 
Abs: fluorescein isothiocyanate (FITC)- conjugated mouse 
CD4 (130- 102- 541, Miltenyi) and phycoerythrin (PE)- 
conjugated human CD2 (hCD2) (347597, BD Bioscience). 
Flow cytometric analysis was performed on a FACSCalibur 
(BD Biosciences) and analyzed with the FlowJo software 
(TreeStar).
4.5 | Immunoblot analysis
NE were prepared with NE- PER Nuclear and Cytoplasmic 
Extraction Reagents (Thermo Fisher Scientific). Aliquots 
of NE (10 μg) were subjected to immunoblot analysis with 
anti- FLAG M2 Ab (F1804, Sigma- Aldrich), as described 
 previously (Fujita & Fujii, 2013).
4.6 | Transduction of gRNA and isolation of 
transduced cells
Transduction of retroviral expression plasmids into pri-
mary CD4+ T cells was performed as described previously 
(Naoe et al., 2007). Briefly, CD4+ T cells were purified 
from spleens using the mouse CD4+ T cell isolation kit 
(Miltenyi, 130- 104- 454). Purified CD4+ T cells were acti-
vated with anti- CD3 Ab (3 μg/ml, 145- 2C11, 553057, BD 
Pharmingen) and anti- CD28 Ab (3 μg/ml, 37.51, 553295, 
BD Pharmingen). A retroviral expression plasmid was 
transfected into Plat- E cells (Morita, Kojima, & Kitamura, 
2000) along with pPAM3 (Miller & Buttimore, 1986) using 
Lipofectamine 3000 (Invitrogen) to produce retroviral par-
ticles. Activated CD4+ T cells were transduced with the ret-
roviral particles by the spin infection method (Naoe et al., 
2007). After culturing for 2 days in RPMI complete media 
T A B L E  1  Oligodeoxyribonucleotides used in this study
Number Name Sequence (5′ → 3′) Experiments
27551 MluI–PmeI oligo- S cacgcgtgtttaaacgagct Construction of pCAG1.2- PM and pCAG1.2- MP
27552 MluI–PmeI oligo- A cgtttaaacacgcgtgagct Construction of pCAG1.2- PM and pCAG1.2- MP
27699 ROSA- 5′ TF2 ctcagagagcctcggctagg Genotyping of all Tg mouse lines
27644 Cas9- R cagggcgataagattaccaaac Genotyping of 3xFLAG- dCas9- IRES- EGFP
26013 oIMR0013 cttgggtggagaggctattc Genotyping of 3xFLAG- dCas9/CTV (neo+/GFP+)
28110 Cas9- R 27643 atggttgggtacttttcatggt Genotyping of 3xFLAG- dCas9/CTV (neo+/GFP+) and 3xFLAG- 
dCas9/CTV (GFP+)
27822 mcMYC promoter 1 
sense
caccgcgcccgggacgtgcgtgacg Construction of gRNA targeting c- myc promoter: sense strand
27823 mcMYC promoter 1 
antisense
aaaccgtcacgcacgtcccgggcgc Construction of gRNA targeting c- myc promoter: antisense 
strand
28157 mcMYC- 0.62k- F tatacgtggcagtgagttgctga enChIP real- time PCR [c- myc (1)]
28158 mcMYC- 0.44k- R ctctaaggctggggaaaacagaa enChIP real- time PCR [c- myc (1)]
28222 mc- myc_- 0.1k- F ctgaggctcctcctcctctttc enChIP real- time PCR [c- myc (2)]
28223 mc- myc_- 0.1k- R cccttccccacctctctctattt enChIP real- time PCR [c- myc (2)]
26574 mGAPDH- prom- F gggttcctataaatacggactgc enChIP real- time PCR (Gapdh)
26575 mGAPDH- prom- R agcatccctagacccgtacagt enChIP real- time PCR (Gapdh)
28091 mPax5- ChIP- prom- F gacctatggaggttgcaattgag enChIP real- time PCR (Pax5)
28092 mPax5- ChIP- prom- R agcaagtggttttgaaccctgta enChIP real- time PCR (Pax5)
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containing mouse IL- 2 (20 ng/ml, 402- ML, R & D Systems), 
transduced cells were analyzed by flow cytometry. hCD2+ 
cells were purified using human CD2 MicroBeads (130- 
091- 114, Miltenyi) and used for enChIP analysis.
4.7 | enChIP real- time PCR
enChIP real- time PCR was performed as described previ-
ously (Fujita & Fujii, 2013) with some modifications. Briefly, 
the CD4+ T cells (ca. 1 × 106) were cross- linked with 0.1% 
formaldehyde in RPMI complete media at 37°C for 10 min. 
After quenching and washing with PBS, the chromatin 
fraction was extracted and fragmented by sonication. The 
sonicated chromatin was used for enChIP using 2 μg of anti- 
FLAG M2 Ab. DNA was purified using ChIP DNA Clean 
& Concentrator (Zymo Research) and subjected to real- time 
PCR. Primers used in the analysis are shown in Table 1.
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